10-QPeriod: Q3 FY2015

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2015

Filed November 5, 2015For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong third-quarter and year-to-date 2015 results, demonstrating robust growth across its diversified platforms. Total revenues surged by 27% year-over-year for the quarter, driven significantly by the impactful acquisition of Catamaran Corporation and continued organic growth within both the UnitedHealthcare and Optum segments. The company also saw a notable 61% increase in Optum revenues, highlighting the synergistic benefits and expanding reach of its technology and services businesses. Despite a slight decrease in UnitedHealthcare's operating earnings due to factors like increased investments in Medicare Star quality performance and the impact of individual public exchange products, the overall earnings from operations saw a healthy 4% increase. This was bolstered by a substantial 32% growth in Optum's operating earnings. Diluted earnings per share saw a modest 1% increase to $1.65 for the quarter. The company's financial position remains solid, supported by strong operating cash flows, which increased by 11% year-to-date, and strategic debt management, underscoring its capacity for continued investment and shareholder returns.

Financial Highlights

56 data points
Beta

Revenue

$41.49B

85.3% Gross Margin

Net Income

$1.60B

3.8% Net Margin

EPS (Diluted)

$1.65

Total Assets

$108.27B

Cash & Equivalents

$7.98B

Free Cash Flow

$2.44B

Financial Statements
Beta
Revenue$41.49B
Cost of Revenue$6.11B
Gross Profit$35.38B
SG&A Expenses$6.18B
Operating Expenses$38.47B
Operating Income$3.02B
Interest Expense$229.00M
Net Income$1.60B
EPS (Basic)$1.68
EPS (Diluted)$1.65
Shares Outstanding (Basic)953.00M
Shares Outstanding (Diluted)967.00M

Key Highlights

  • 1Consolidated revenues grew 27% year-over-year in Q3 2015, reaching $41.5 billion, largely due to the Catamaran acquisition and organic growth.
  • 2Optum segment revenues surged by 61% to $19.3 billion in Q3 2015, demonstrating strong performance and strategic expansion.
  • 3UnitedHealthcare experienced revenue growth of 9% to $32.8 billion in Q3 2015, serving an additional 1.7 million people domestically.
  • 4Earnings from operations increased by 4% to $3.0 billion in Q3 2015, with Optum's earnings up 32% and UnitedHealthcare's down 8%.
  • 5Diluted earnings per share rose by 1% to $1.65 for the three months ended September 30, 2015.
  • 6Year-to-date cash flows from operations were $6.2 billion, an increase of 11% compared to the same period in 2014.
  • 7The company acquired Catamaran Corporation on July 23, 2015, for $14.3 billion, significantly impacting reported revenues and goodwill.

Frequently Asked Questions

The primary driver of the significant revenue increase in the third quarter of 2015 was the acquisition of Catamaran Corporation on July 23, 2015, which contributed substantially to the reported revenues. Organic growth across both the UnitedHealthcare and Optum segments also played a significant role.

The acquisition of Catamaran significantly increased total assets and liabilities on the balance sheet. It also led to a substantial increase in consolidated revenues, particularly within the OptumRx segment, and resulted in a significant increase in goodwill and intangible assets on the balance sheet. While Catamaran contributed to revenue, its impact on net earnings for the period was immaterial.

The company continues its share repurchase program, although activity was moderated in the third quarter due to the Catamaran acquisition. As of September 30, 2015, there was authorization to repurchase up to 61 million shares. In June 2015, the Board increased the quarterly cash dividend to an annual rate of $2.00 per share.

Key regulatory challenges include ongoing changes to Medicare Advantage rates, the Health Insurance Industry Tax, and the stabilization programs associated with health reform legislation. The company is also adapting to evolving participation in public and private health insurance exchanges. Government investigations, audits, and reviews by various agencies remain a factor, though specific potential impacts are difficult to quantify.